Your session is about to expire
← Back to Search
Smartphone App for Cancer Medication Adherence
N/A
Recruiting
Led By Melissa Accordino, MD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
Study Summary
This trial will study whether a Medisafe App can help improve medication adherence in cancer patients receiving either oral anticancer agents or oral medications for chronic disease management.
Who is the study for?
This trial is for cancer patients of any stage or type who are taking oral anticancer drugs or other medications for chronic conditions alongside their cancer treatments. Participants must be able to fill out questionnaires in English or Spanish, have a smartphone or tablet compatible with the Medisafe App, and can consent to join.Check my eligibility
What is being tested?
The study tests if a smartphone app (Medisafe App) helps cancer patients take their medication on time. It's not random; everyone gets the app and researchers will see if it improves how well they follow their medication schedule over 12 weeks using surveys and interviews.See study design
What are the potential side effects?
Since this trial involves using an app rather than a drug, there aren't typical medical side effects. However, participants may experience issues related to technology use such as frustration with the app interface or privacy concerns.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Proportion of subjects enrolled that complete the 12-week intervention and assessments
Secondary outcome measures
Change in Patient-Reported Outcomes Measurement Information System (PROMIS) 29 Score before and after the intervention
Change in Treatment Satisfaction Questionnaire for Medication (TSQM) Domain Score before and after the intervention
Change in mean score on the Voils Extent of Adherence Scale for global medication use between baseline and 12 weeks
+3 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Smartphone App InterventionExperimental Treatment1 Intervention
Cancer patients taking at least one oral anti-cancer drug or oral medication to manage a chronic condition in conjunction with any cancer treatment will receive messages through the Medisafe App.
Find a Location
Who is running the clinical trial?
Columbia UniversityLead Sponsor
1,431 Previous Clinical Trials
2,460,731 Total Patients Enrolled
Melissa Accordino, MDPrincipal InvestigatorAssistant Professor of Medicine
3 Previous Clinical Trials
222 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have cancer, regardless of its type or stage.I can download the Medisafe App on my phone or tablet.I can fill out questionnaires in English or Spanish by myself.I am taking oral medication for cancer or a chronic condition while also receiving non-oral cancer treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Smartphone App Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many individuals have registered for this clinical experiment?
"Affirmative. Clinicaltrials.gov shows that recruitment for this clinical trial, which was initially listed on January 15th 2020, is still active. The study seeks to enrol 100 patients at a single site."
Answered by AI
Are there vacancies available to participate in this experiment?
"Clinicaltrials.gov reveals that this research endeavour, first published in mid January of 2020 and most recently revised on the 25th of 2021, is actively seeking participants."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger